-
Abnormal Distribution of B-Cell Populations Associated with Impaired Regulatory Functions in Chronic Antibody Mediated Rejection
-
ABO Antibody Removal of Plasmapheresis (PP) with Intravenous Immunoglobulin (IVIG) before ABO-Incompatible (ABOI) Kidney Transplantation
-
ABO Incompatible Kidney Transplantation Using Subcutaneous Alemtuzumab for Induction and No Post Transplant Plasmapheresis
-
ABO-Incompatible Kidney Transplantation Protects the Graft from Natural Antibodies Induced Damage and Prevents Immune Responses to Donor HLA and Kidney Associated Self Antigens Leading to Long Term Rejection Free Survival
-
Abrogation of Chronic Rejection Involves Down Regulation of mTOR/Rac1 Pathway
-
Absence of the MicroRNA miR-182 in CD4+T Cells Prolongs Allograft Survival
-
Accelerated Hepatic Fibrosis after Renal Transplantation: Long-Term Outcomes in HCV+ Patients
-
Accept/Decline Decisions for Deceased Donor Liver Allografts
-
Activated T Regulatory Cells Escape Death by Increasing Cytoplasmic Serine Protease Inhibitor 6 (SPI6)
-
Actuarial Perspective on the Annual Per Patient Maintenance Immunosuppressive Medication Costs for Transplant Recipients: 1993-2011, An
-
Acute Diverticulitis Incidence, Management, and Outcomes in Solid Organ Transplant Patients
-
Acute Kidney Injury in Kidney Transplant Patients According to the Rifle and Akin Criteria
-
Acute Rejection in Older Kidney Transplant Recipients
-
Acute Rejection Is Associated with Increased Microvascular Tortuosity and a Dysbalance in Angiopoietins up to 1 Year after Rejection
-
Acute Rejection on Surveillance Biopsies Is a Predictor of Functional Decline in Kidney Transplants over Long-Term Follow-Up
-
Acute T-Cell Mediated Rejection with Severe Tubulitis or Mild Intimal Arteritis: Which Histological Lesion Predicts Better Graft Outcome?
-
Addition of Anti-CMV Ig to Routine CMV Prophylaxis in EBV High Risk Kidney Transplant Recipients Is Associated with Reduced PTLD Incidence
-
Adherence with Immunosuppressive Therapy: Results to 4 Years after Kidney Transplantation in the Mycophenolic Acid Observational Renal Transplant (MORE) Study
-
Adjunctive Bortezomib Therapy for Treatment of Antibody Mediated Rejection in Kidney Transplant Recipients
-
Advagraf Immunosuppression Initiation in Kidney and Liver Transplant Recipients: 3 Month-Interim Analysis of a French Multicenter Observational Study
-
Adverse Events of Over-Immunosuppression Are Dependent on Tofacitinib Exposure in Kidney Transplant (KT) Patients
-
Age and Antimetabolites: Appropriate Candidate Selection Drives Success
-
Age Disparities in Discussions about Kidney Transplantation among Dialysis Patients
-
Aggravation of Post-Ischemic Liver Injury by Overexpression of IGFBP-3
-
Aggregate Annual Health Care Expenditures Associated with Lung Transplantation in the United States: 1988-2011
-
Aggregate Impacts of the CMS CoP on Patient and Donor Characteristics
-
Agonistic Anti-BTLA mAb (3C10) Induced Prolongation of Murine Cardiac Allograft and Generation of IL-10 Dependent Regulatory CD4+ T Cells, An
-
Alemtuzumab as Anti-Rejection Therapy in Kidney Transplant Patients Induces Homeostatic T Cell Proliferation and Impairs IL7 but Not IL2 Responses
-
Alemtuzumab for Induction Therapy for Small Bowel Transplantation
-
Alemtuzumab Induction and Belatacept-Based Immunosuppression in Renal Transplant Recipients: Peripheral Dynamics of T and B Cell Populations with Potential Regulatory Signatures
-
Alemtuzumab Induction and Steroid Free Maintenance in Predominately African American Renal Allograft Recipients
-
Alemtuzumab Induction in HCV Seropositive Kidney Transplant Recipients
-
Alemtuzumab Induction in Simultaneous Pancreas and Kidney Transplantation
-
Alemtuzumab Induction Results in Higher Rates of Leucopenia and Opportunistic Viral Infections in Renal Transplant Recipients
-
Alemtuzumab Induction with Tacrolimus Monotherapy vs TAC+MMF Bitherapy in Pancreas Transplant Recipients: 10 Year Experience
-
Alemtuzumab Mitigates the Risk of Early Rejection Associated with Delayed Graft Function in Deceased Donor Renal Transplantation
-
Alemtuzumab vs Antithymocyte Globulin Induction in Pediatric Renal Transplant Recipients: Our Single-Center Experience with 3 Year Follow-Up
-
All-Trans Retinoic Acid and Rapamycin Synergize with Transforming Growth Factor-β To Induce Regulatory T Cells but Confer Distinct In Vivo Migratory Capacities
-
All-Trans Retinoic Acid Promotes the Development of Inducible Nitric Oxide Synthase Producing Dendritic Cells with T Cell Suppressive Function
-
Alloantibody-Induced C4d Deposition, without Activation of Distal Complement Effectors C5a and C5b-9, Is Not Associated with Kidney Allograft Injury or Accommodation in Mice
-
Alloantigen-Specific Tregs Can Be Identified by Activation-Induced CD154 Expression
-
Allocating Deceased Donor Kidneys to High PRA Patients: A Simulation
-
Alloimmune and Non-Alloimmune Kidney Graft Losses, Improving Our Understanding of Factors Associated with Failure
-
Alpha 1-Antitrypsin (A1AT) Prevents Pulmonary Ischemia Reperfusion Injury in Rats
-
Altered Serum miR-326 and miR-142-3p Profiles during Acute Rejection after Heart Transplantation
-
Amnion-Derived Multipotent Progenitor Cells Support Allograft Tolerance Induction
-
AMPK Activator Promotes, but Complement and Thrombin Inhibit Anti-A/B Antibody-Induced Accommodation in Endothelial Cells
-
Analysis of Graft Loss in Hand Transplant Recipients in the Western World – Cause for Concern?
-
Analysis of Leukocyte-Endothelium Interactions after Immunosuppression by Means of Intravital Microscopy in the Human Placenta
-
Analysis of miRNAs in Peripheral Blood Mononuclear Cells: Potential Value of miR-182 as a Biomarker of Chronic Antibody Mediated Rejection
-
Analysis of Motivation and Anonymity in 117 Unspecified (Altruistic) Donors in the UK
-
Analysis of Patient Survival Outcome between Waiting List Adult HUS Patients Who Received Kidney Transplants (KT) and Those Who Did Not
-
Analysis of Portal Vein Reconstruction for LDLT Recipients with Portal Vein Thrombus
-
Analysis of Survival and Neoplasm Recurrence in Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma: Association with Immunohistochemical Profile and Tumor Characteristics
-
Anchoring Heparin to the Surface of Islet Improved Revascularization in Islet Transplantation
-
Angiopoietin2: A Prognostic Marker in Kidney Transplantation
-
Antagonists of Bone Morphogenetic Protein Signaling Promote Liver Regeneration and Repair in Mice
-
Anti HLA Immunisation Related to Skin Allograft in Extensively Burned Patients: Assessment in Potential Candidates for Vascularized Composite Allotransplants
-
Anti-Angiotensin Type 1 Receptor Antibodies Associated with Rejection in Donor HLA Antibody Negative Recipients
-
Anti-CD20 Antibody Therapy for Antibody-Mediated Rejection of Renal Allografts in a Mouse Model
-
Anti-CD3 Accelerated Diabetes in Transgenic Non-Obese Diabetic (NOD) Mice Expressing miRNA Decoy Sequence(s)
-
Anti-ER-TR7 mAb Prevents Tolerogenic Lymph Node Morphogenesis and Overrides Transplant Tolerance
-
Anti-HLA DP Alpha Alloantibodies Are Associated with High Antibody Levels and Correlate with Individual HLA-DP Beta Epitopes in Renal Transplant Candidates and Recipients
-
Anti-HLA Immunization Profile at the Time and after Renal Allograft Nephrectomy
-
Anti-Hyperglycemic Effect of Ginseng on Cyclosporine-Induced Diabetes Is Related to the Direct Pancreatic Islet Cell Protection
-
Anti-IL-6 Receptor (Anti-IL6R) Treatment Is Effective in Reducing Recall Antibody Responses in Sensitized HLA-A2 Skin Graft Recipients
-
Anti-IL6R Suppresses Primary IgM Response and CD5+ B-1a Cell Subset Stimulated by HLA.A2+ Skin Allografts
-
Anti-Inflammatory Effects of Prednisolone Treatment Did Not Improve Organ Quality in Brain Dead Rats
-
Anti-Perlecan Antibodies Are Novel Accelerators of Immune-Mediated Vascular Injury
-
Anti-TIM-4 Mediates Long-Term Engraftment of Islet Allografts by Promoting IL-10 Expression by TIM-1+ Bregs and Inhibiting IFNγ Expression by Proinflammatory “Be1” B Cells
-
Antibodies Are Not Necessarily Detrimental to the Graft Survival – Single Centre Experience in Living Donor Renal Transplantation
-
Antibodies to K-α1 Tubulin and IL 17 Induces Periostin Dependent Pro-Fibrotic Signaling Cascades: A Novel Biomarker Involved in the Pathogenesis of Chronic Lung Allograft Rejection
-
Antibody Targeting the TCR β-Chain Selectively Abrogates Antigen-Specific T Cell Responses by Modulating T Cell Transcriptional Patterns
-
Antibody-Mediated Injury Is the Major Cause of Late Kidney Allograft Failure
-
Antibody-Mediated Rejection (AMR) in Kidney Transplantation: The Role of Anti-Peroxisomal trans-2-enoyl-CoA Reductase (PECR) Auto-Antibody
-
Antithymocyte Globulin Induction Is Associated with Improved Graft Survival and Reduced Ischemic Cholangiopathy after DCD Liver Transplantation as Compared to Basiliximab
-
Antithymocytes Globulines and Immune Senescence in Renal Transplant Patients
-
Antiviral Prophylaxis for HBsAg-Positive Renal Transplant Recipients Treated with Rituximab®
-
APOL1 and MHY9 Gene Variants and Allograft Outcomes in Kidney Transplantation
-
Application of Rejection Reversal as Defined by Efficacy Endpoints in Present Day Renal Transplantation
-
Arachidonate Lipoxygenase Controls the Suppressive Function of Myeloid Derived Suppressor Cells
-
Are Preemptive Deceased Donor Kidney Transplants Equitable?
-
Are Some “High-Risk” Renal Transplants Recipients Higher Risk Than Others?
-
Arterial Stiffness in Kidney Transplantation: Relationship with Dipper Status on Ambulatory Blood Pressure Monitoring
-
Arteriosclerosis in Histological Evaluations Using Zero-Time Biopsy Is a Risk Factor for Tacrolimus-Induced Nephrotoxicity
-
Assessing Cell Mediated Immunity (CMI) Status by the ImmuKnow Assay in Renal Transplant Recipients
-
Assessing the Validity of the Kidney Donor Profile Index (KDPI): The MedStar Washington Hospital Center Experience
-
Assessment of Anti-A and Anti-B Antibody Titers in Different IVIG Preparations: Correlation with Risk for Hemolysis
-
Assessment of CMV Antiviral Resistance Mutations in Clinical Samples
-
Assessment of Hypercoagulability in Pediatric Liver Transplant Patients
-
Assessment of Preventable and Non-Preventable Early Rehospitalization Following Kidney Transplantation
-
Assessment of the Time to Therapeutic Tacrolimus Levels and the Incidence of Rejection in Heart Transplant Patients
-
Assessment of the Time-Dependent Effect of Blood Pressure on the Risk of Graft Failure in Kidney Transplant Recipients Using a Marginal Structural Model, An
-
Assessment of Visit-to-Visit Blood Pressure Variability in Living Kidney Donors and Healthy Two-Kidney Controls
-
Assessment of Vitamin D and Changes in Bone Mineral Density in a Predominantly African American Pediatric Kidney Transplant Population
-
Association between CMV Infection and Subsequent BKV Infection after Kidney and Kidney/Pancreas Transplant – 4.5 Years of Experience in a Single Center, The
-
Association between De Novo Post-Transplant Nonmelanoma Skin Cancer and Solid Tumor after Solid Organ Transplantation – An Analysis of OPTN/UNOS Data
-
Association between Early Progression in Chronic Kidney Disease Stage Following Liver Transplantation and Graft Survival
-
Association between Methods of Proteinuria Screening and the Metabolic Syndrome in Potential Living Kidney Donors
-
Association between TGFBR2 Gene Polymorphism (rs2228048, Asn389Asn) and Acute Rejection in Korean Kidney Transplantation Recipients
-
Association between the CYP3A5*1 Allele, Tacrolimus Concentrations and Renal Function in Lung Transplant Recipients
-
Association of B Cell Population in Splenic Histology of ABO Incompatible Kidney Transplantation and One-Year Graft and Recipient Survival, The
-
Association of Brain Death Donor Cytokinemia with Donor and Recipient Renal Function in the Steroid Era
-
Association of HLA Amino Acid Mismatches with Kidney Allograft Failure
-
Association of HLA-A, B, C, DR, and DQ Matching with Rejection and Survival in Pancreas Transplantation
-
Association of Interferon-γ Gene Polymorphisms with Cytomegalovirus Viremia in Renal Allograft Recipients
-
Association of Pancreas Auto-Antibodies (AA) with Donor Specific Anti-HLA Antibodies (DSA) and Pancreatic Allograft Function
-
Association of the Six-Minute Walk Test (6MWT) with Prevalent Cardiovascular Disease (CVD) in a Renal Transplant Evaluation Clinic, The
-
Association of Vitamin D and Albuminuria in Renal Transplant Recipients, The
-
Associations between Clinical, Biochemical Indicators and Anthropometric Measurements with Arterial Stiffness in Renal Transplantation Patients
-
Associations of Estimated GFR and Urinary Protein Excretion with Mortality and Graft Failure Following Kidney Transplantation
-
Associations of Nephrosclerosis with Kidney Function and Size in Living Kidney Donors (LKD)
-
Asymptomatic Acute Transplant Pyelonpehritis: A Single-Center Experience
-
ATG Induction for Sensitized Patients Who Have Undergone Heart Transplant: Is It Beneficial?
-
ATP-Competitive mTORC1 and 2 Inhibitors Are a Novel Class of Immunosuppressants That Suppress Allograft Rejection
-
Autophagy-Deficient T Cells Are Resistant to Cell Death after Costimulatory Blockade
-
Autosomal Dominant Polycystic Kidney Disease (PKD) Evaluated for Renal Transplantation. A Single Center Experience at Emory Transplant Center
-
Axin2/β-Catenin/Notch1 Sigaling Regulates Innate Immunity in Mouse Model of Liver Ischemia/Reperfusion Injury
2013 American Transplant Congress
May 18-22, 2013 in Seattle, Washington